Bausch Health Companies BHC Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bausch + Lomb | $5.21B+7.8% | $5.1B+6.5% | $4.98B+6.2% | $4.89B+8.8% | $4.83B+11.9% | |
| Diversified | $917M-3.8% | $937M-1.4% | $910M-7.2% | $921M-5.1% | $953M+0.5% | |
| International | $1.16B+4.2% | $1.13B+1.9% | $1.11B-1.5% | $1.11B+0.4% | $1.11B+1.7% | |
| Salix | $2.68B+12.6% | $2.58B+10.5% | $2.52B+10.4% | $2.45B+8.5% | $2.38B+5.5% | |
| Solta Medical | $576M+23.9% | $518M+17.7% | $519M+28.1% | $491M+30.6% | $465M+28.5% | |
| Revenue by Product | ||||||
| Other revenues | $102M-11.3% | $110M+2.8% | $113M+10.8% | $117M+18.2% | $115M+19.8% | |
| Price Appreciation Credit | $18M-10.0% | $18M0.0% | $21M+90.9% | $20M+81.8% | $20M+81.8% | |
| Product sales | $10.43B+8.5% | $10.16B+6.7% | $9.92B+5.8% | $9.74B+7.0% | $9.62B+8.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch Health Companies break its business down?
- Bausch Health Companies (BHC) reports revenue by business across 5 parts — Bausch + Lomb, Diversified, International, Salix and Solta Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch Health Companies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch Health Companies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.